Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Takeda
Universität des Saarlandes
National Institutes of Health Clinical Center (CC)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Children's Cancer Group, China
Ohio State University Comprehensive Cancer Center
Boehringer Ingelheim
BeiGene
Children's Oncology Group
Takeda
Takeda
Children's Oncology Group
University of Nebraska
European Organisation for Research and Treatment of Cancer - EORTC
University of Nebraska
City of Hope Medical Center
The Lymphoma Academic Research Organisation
University of Nebraska
University of Nebraska
Eastern Cooperative Oncology Group
University of Milano Bicocca
National Institutes of Health Clinical Center (CC)
Columbia University
National Institutes of Health Clinical Center (CC)
Children's Cancer Group, China
Gustave Roussy, Cancer Campus, Grand Paris
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Seagen Inc.
Northwestern University
Takeda
Roswell Park Cancer Institute
Universität des Saarlandes
Universität des Saarlandes
Takeda
Masonic Cancer Center, University of Minnesota
Children's Hospital Medical Center, Cincinnati
Mayo Clinic
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Columbia University
Takeda
Children's Oncology Group
Novartis
National Cancer Institute (NCI)
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Canadian Cancer Trials Group